News The CHMP Recommends Conditional Approval of Regeneron’s Linvoseltamab to Treat R/R Multiple Myeloma (MM)ByDipanshu DixitMarch 3, 20250Comments
News Krystal Biotech’s Vyjuvek (beremagene geperpavec) Receives the CHMP’s Positive Opinion for Dystrophic Epidermolysis Bullosa (DEB)ByRidhi RastogiMarch 3, 20250Comments
News Magnet Biomedicine Partners with Eli Lilly to Advance Molecular Glue Therapeutics in OncologyByRidhi RastogiMarch 3, 20250Comments
VIEWPOINTS Enhancing Autoimmune Care: Caterina Brindicci from AstraZeneca in a Riveting Conversation with PharmaShotsBySaurabh ChaubeyMarch 3, 20250Comments
News Fresenius Kabi Launches Otulfi (Biosimilar, Stelara) in the US ByDipanshu DixitMarch 3, 20250Comments
Weekly Snapshot PharmaShots Weekly Snapshots (February 24, 2025 – February 28, 2025)BySenior EditorFebruary 28, 20250Comments
News ALK Reports US FDA Approval of Odactra to Treat Children with House Dust Mite AllergyByRidhi RastogiFebruary 28, 20250Comments
News Janssen’s Type II Variation for Carvykti (ciltacabtagene autoleucel; cilta-cel) Receives CHMP’s Positive Opinion to Treat Multiple Myeloma ByDipanshu DixitFebruary 28, 20250Comments
News Fapon Biopharma Reports the US FDA Approval of IND Application for FP008 to Treat Solid TumorsByRidhi RastogiFebruary 28, 20250Comments
